Comment and Reply on:: Relative efficacy effectiveness and relative costs of treatment with insulin glargine and insulin detemir

被引：1
|
作者：
Freemantle, Nick [1 ]
Stella, Peter [1 ]
Munro, Vicki [1 ]
机构：
[1] Univ Birmingham, Hlth Care Evaluat Grp, Birmingham B15 2TT, W Midlands, England
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2007年 / 23卷 / 08期
关键词：
D O I：
10.1185/030079907X210813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1761 / 1762
页数：2
相关论文
共 50 条
  • [1] Comment and Reply on:: Relative efficacy effectiveness and relative costs of treatment with insulin glargine and insulin detemir -: Reply
    Currie, Craig J.
    Poole, Chris D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) : 1762 - 1764
  • [2] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
  • [3] Costs analysis of type 2 diabetes mellitus treatment with insulin glargine or detemir
    Alvarez Guisasola, F.
    Mauricio Puente, D.
    Garcia Coscolin, T.
    Betegon Nicolas, L.
    Rubio-Terres, C.
    AVANCES EN DIABETOLOGIA, 2010, 26 (06): : 430 - 435
  • [4] The relative cost effectiveness of insulin glargine versus detemir insulin using UK real life data in patients with type 2 diabetes mellitus
    Tetlow, A. P.
    McEwan, P.
    Gordon, J.
    DIABETOLOGIA, 2008, 51 : S406 - S406
  • [5] Comparative analysis of treatment outcomes of patients on insulin detemir and insulin glargine
    Alemayehu, B.
    Borah, B.
    Henk, H.
    Aagren, M.
    Forma, F.
    DIABETOLOGIA, 2008, 51 : S406 - S407
  • [6] Assessing differences in utilization and costs between insulin detemir (Levemir®) and insulin glargine (Lantus®) users
    Borah, B.
    Alemayehu, B.
    Henk, H. J.
    Forma, F. M.
    VALUE IN HEALTH, 2008, 11 (03) : A228 - A228
  • [7] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
    McEwan, P.
    Poole, C. D.
    Holmes, P.
    Tetlow, A. P.
    Currie, C. J.
    VALUE IN HEALTH, 2006, 9 (06) : A225 - A226
  • [8] Comparative study of annual treatment costs of glargine insulin and detemir insulin in patients with type 2 diabetes mellitus in Spain
    Alvarez Guisasola, F.
    Casal LLorente, C.
    Rubio-Terrés, C.
    Betegon, L.
    Echevarria, A.
    VALUE IN HEALTH, 2007, 10 (06) : A267 - A267
  • [9] Allergy to insulin detemir and glargine as alternative
    Sanchez-Gonzalez, M.
    Blanca-Lopez, N.
    Seoane, E.
    Jaramillo, J.
    Blanco, S.
    Mohedano, E.
    Canto, G.
    ALLERGY, 2008, 63 : 374 - 375
  • [10] COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL
    Pichon-Riviere, A.
    Caporale, J. E.
    von Schulz-Hausmann, C.
    Augustovski, F. A.
    VALUE IN HEALTH, 2009, 12 (07) : A505 - A505
12345